Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO


NEW YORK, Aug. 13, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited ("Mesoblast" or the "Company") (NASDAQ: MESO).  Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Mesoblast and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On August 11, 2020, the U.S. Food and Drug Administration ("FDA") released briefing materials for the August 13, 2020 meeting of the FDA's Oncologic Drugs Advisory Committee, at which the FDA will review and discuss Mesoblast's marketing application for Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.  The FDA briefing documents stated that it is "unclear" whether the study results supporting Mesoblast's application are "relevant" to the proposed indication for use. 

On this news, Mesoblast's stock price fell $6.09 per share, or 34.96%, to close at $11.33 per share on August 11, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com 
888-476-6529 ext. 7980

 

SOURCE Pomerantz LLP


These press releases may also interest you

at 17:05
U.S. Bancorp will host conference calls to review quarterly financial results on the following dates: Fourth Quarter 2020 ? Wednesday, January 20, 2021, at 8 a.m. CT First Quarter 2021 ? Thursday, April 15, 2021, at 9 a.m. CT Second Quarter...

at 17:05
PotlatchDeltic Corporation will release third quarter earnings on Monday, October 26th, after the market closes. A live conference call and webcast will be hosted by Michael J. Covey, chairman and chief executive officer, on Tuesday, October 27th at...

at 17:00
via NetworkWire ? Kaival Brands Innovations Group, Inc. ("Kaival Brands," the "Company," or "we"), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, is proud to announce its entry into a...

at 17:00
Agnico Eagle Mines Limited  ("Agnico Eagle" or the "Company") today announced that it will release its third quarter 2020 results on Wednesday, October 28, 2020, after normal trading hours. Third Quarter 2020 Results Conference Call Webcast Agnico...

at 16:59
Trading resumes in: Company: Newcore Gold Ltd. TSX-Venture Symbol: NCAU All Issues: Yes Resumption (ET): 8:00AM 09/29/2020 IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company....

at 16:59
Flagship Communities Real Estate Investment Trust (the "REIT") announced today that it has filed, and obtained a receipt for, a final long-form prospectus for its initial public offering (the "Offering") of trust units of the REIT ("Units") with the...



News published on 13 august 2020 at 21:57 and distributed by: